A new blood test is more reliable at finding prostate cancer in its early stages by detecting a protein marker in blood plasma. Doctors say the new test, now in clinical trials, will have an accuracy of 95 percent, better than the commonly used PSA, which signals abnormal prostate conditions rather than cancer.
Hosted by sciencedaily.com
Creator's Site: www.sciencedaily.com
Curated By: Bobinski